102 Chapter 5 Table S2. Characteristics of isolates of patients that were treated with systemic antibiotics Isolate Treatment regimen/ duration MIC/ susceptibility resistance genes DX MIC/ susceptibility resistance genes VA Disk zone/ susceptibility resistance genes TR 7346 DX RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S 21 / S - - - 0037 TR RA MP / 7 ≥ 16.0 / R ≤ 0.5 / S 24/ S tet(K) - - 2654 DX RA MP / 7 ≤ 1.0 / S 1 / S 23 / S - - - 502760 SXT RA MP / 14 ≥ 16.0 / R 1 / S 17 / S tet(L) - - 3025 DX RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S 22 / S - - - 5606 SXT RA MP / 7 ≤ 1.0 / S 1 / S 27 / S - - - 6118 TR RA MP / 7 ≥ 16.0 / R 1 / S 23 / S tet(K) - - 7435 TR RA MP / 7 ≤ 1.0 / S - / - - / S - - - 7473 TR RA MP / 7 ≥ 16.0 / R 1 / S 19 / S tet(K) - - 7761 SXT RA MP / 7 ≥ 16.0 / R 1 / S 20 / S tet(K) - - 8852 SXT RA MP / 7 ≤ 1.0 / S 1 / S 22 / S - - - 0507 DX RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S - / R - - - 1475 DX RA MP / 14 ≤ 1.0 / S 1 / S 6 / R - - - 2285 DX RA MP / 14 ≤ 1.0 / R 1 / S 20 / S - - - 3460 SXT RA MP / 7 ≤ 1.0 / R 1 / S 21 / - - - - 5940 DX RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S - / R - - - 8413 DX RA MP / 7 ≤ 1.0 / S 1 / S 6 / R - - dfrG 2213 SXT RA MP / 7 ≥ 16.0 / R 1 / S 21 / S
RkJQdWJsaXNoZXIy MTk4NDMw